Background
Gadolinium concentration variation during acquisition of contrast‐enhanced MR angiography (CE‐MRA) may lead to artifacts.
Purpose
To compare signal intensity (SI) profiles of four different contrast agent injection strategies during CE‐MRA with the goal of minimizing SI variation during acquisition.
Study Type
Prospective.
Subjects
Forty subjects randomized to receive one of four injection profiles of gadobenate dimeglumine (0.1 mmol/kg), either undiluted (0.5 M) or diluted to 40 ml total volume. Tested profiles: 1) nondiluted single‐phase ("standard" NS; 1.6 ml/s), 2) diluted single‐phase (DS; 1.6 ml/s), 3) diluted biphasic (DB; 9 ml @ 3.3 ml/s, 29 ml @ 1.4 ml/s), 4) patient‐tailored protocol using linear prediction (DT).
Field Strength/Sequence
Time‐resolved SI measured at 3T with spoiled gradient echo sequences having analogous parameters to those of CE‐MRA.
Assessment
Plateau arrival time, rise time, duration, peak and tail SI, plateau quality (sum of squared residuals; SSR), average SI for each injection type derived were used.
Statistical Test
Two‐tailed t‐test.
Results
Peak SI, arrival, and rise times were not significantly different between groups, excepting peak SI DB slightly > DS (P = 0.042). Duration of NS vs. the diluted groups was significantly shorter (all P < 0.0001), and DS duration was significantly shorter than that of DT and DB (NS 11.4 ± 3.5 vs. DS 22.9 ± 4.3, DB 25.4 ± 2.3, DT 28.3 ± 4.1 sec). Quality (SSR) of the 20‐second plateau was significantly better for DS, DB, DT as compared with NS (all P < 0.001).
Data Conclusion
Three different strategies to power‐inject diluted gadobenate dimeglumine targeting a 20‐second plateau produced SI profiles with longer duration, more consistent plateau, and no significant loss in peak SI. Such injection profiles may provide more uniform SI during CE‐MRA, potentially reducing blurring artifacts.
Level of Evidence: 2
Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2019;50:1808–1816.